• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    37 Stocks Moving In Thursday's Mid-Day Session

    6/16/22 12:43:27 PM ET
    $ACIU
    $ACLX
    $ACOR
    $ADN
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care
    Get the next $ACIU alert in real time by email

     

    Gainers

    • Advent Technologies Holdings, Inc. (NYSE:ADN) shares jumped 153% to $2.94 after the company announced it received notification of euro 782.1 million of funding from the Greek State for the IPCEI Green HiPo project.
    • Pennsylvania Real Estate Investment Trust (NYSE:PEI) shares gained 97.8% to $7.81.
    • Acorda Therapeutics, Inc. (NASDAQ:ACOR) gained 72% to $0.70 after the company announced Esteve Pharmaceuticals GmbH launched INBRIJA in Germany.
    • Heart Test Laboratories, Inc. (NASDAQ:HSCS) jumped 68.2% to $2.8601 following’s Wednesday IPO.
    • Sidus Space, Inc. (NASDAQ:SIDU) shares jumped 62.6% to $7.65. Sidus Space shares jumped 225% on Wednesday after the company announced it is part of Collins Aerospace team which was awarded NASA's Exploration Extravehicular Activity services contract with a potential value of $3.5 billion.
    • Electric Last Mile Solutions, Inc. (NASDAQ:ELMS) rose 63.3% to $0.2299 after declining around 15% on Wednesday. Electric Last Mile Solutions recently announced plans to file for Chapter 7 bankruptcy.
    • Vivakor, Inc. (NASDAQ:VIVK) gained 52.5% to $2.70 after the company announced it signed a definitive agreement to acquire Silver Fuels Delhi and White Claw Colorado City.
    • Lytus Technologies Holdings PTV. Ltd. (NYSE:LYT) gained 47% to $25.00. Lytus Technologies priced its IPO at $4.75 per share.
    • Cango Inc. (NYSE:CANG) gained 26.8% to $2.84.
    • Flora Growth Corp. (NASDAQ:FLGC) rose 21.4% to $0.85. Flora Growth announced $5 million share repurchase program.
    • HeartCore Enterprises, Inc. (NASDAQ:HTCR) jumped 18.8% to $1.9601.
    • VIA optronics AG (NYSE:VIAO) gained 16% to $2.6120.
    • Bon Natural Life Limited (NASDAQ:BON) jumped 13.7% to $3.90.
    • NuZee, Inc. (NASDAQ:NUZE) gained 13.6% to $1.1699.
    • Bone Biologics Corporation (NASDAQ:BBLG) shares rose 12.7% to $1.3527.
    • Biotricity, Inc. (NASDAQ:BTCY) jumped 11.4% to $1.27.
    • Redbox Entertainment Inc. (NASDAQ:RDBX) shares gained 11.1% to $12.18 after gaining around 9% on Wednesday.
    • AeroClean Technologies, Inc. (NASDAQ:AERC) shares rose 9% to $20.55. The company announced on June 7th the FDA granted clearance for the company's pūrgo technology, classifying it as a class II medical device.

     

    Losers

    • Ebix, Inc. (NASDAQ:EBIX) shares dipped 27.1% to $17.06.
    • Mobiquity Technologies, Inc. (NASDAQ:MOBQ) dropped 24.5% to $1.1250.
    • PROG Holdings, Inc. (NYSE:PRG) fell 20.1% to $19.16 after the company cut FY22 adjusted EPS and sales guidance below estimates.
    • AC Immune SA (NASDAQ:ACIU) fell 19.8% to $2.2950 after the company announced crenezumab did not statistically significantly slow or prevent cognitive decline in people with a specific genetic mutation which causes early-onset Alzheimer's disease.
    • SpringBig Holdings (NASDAQ:SBIG) fell 19.8% to $3.61. springbig completed its merger with Tuatara Capital.
    • Green Giant Inc. (NASDAQ:GGE) dipped 19.3% to $0.9599.
    • Arcellx, Inc. (NASDAQ:ACLX) fell 19.2% to $14.11. Arcellx priced an upsized underwritten follow-on offering of 7 million at $16 per share from the original 4 million shares.
    • Embark Technology, Inc. (NASDAQ:EMBK) fell 17.5% to $0.5369.
    • SOPHiA GENETICS SA (NASDAQ:SOPH) dipped 17.1% to $2.32.
    • Connexa Sports Technologies Inc. (NASDAQ:CNXA) fell 16.7% to $1.6401.
    • Visionary Education Technology Holdings Group Inc. (NASDAQ:VEDU) dropped 16% to $1.1099.
    • IsoPlexis Corporation (NASDAQ:ISO) fell 15.6% to $2.05.
    • Outbrain Inc. (NASDAQ:OB) dropped 14.9% to $4.73. Jefferies maintained Outbrain with a Buy and lowered the price target from $9 to $8.
    • AirSculpt Technologies, Inc. (NASDAQ:AIRS) tumbled `14.8% to $6.96. Morgan Stanley downgraded AirSculpt Technologies from Overweight to Equal-Weight and lowered the price target from $17 to $8.5.
    • Sally Beauty Holdings, Inc. (NYSE:SBH) dropped 13.3% to $11.66 after Morgan Stanley downgraded the stock from Equal-Weight to Underweight and lowered its price target from $19 to $12.
    • Koninklijke Philips N.V. (NYSE:PHG) fell 9.2% to $20.52.
    • ShiftPixy, Inc. (NASDAQ:PIXY) fell 8.7% to $0.2702 after dipping 15% on Wednesday.
    • Missfresh Limited (NASDAQ:MF) fell 7.8% to $0.2282.
    • Cepton, Inc. (NASDAQ:CPTN) fell 7% to $1.35. Cepton, is set to join the Russell 3000® Index.

     

    Get the next $ACIU alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ACIU
    $ACLX
    $ACOR
    $ADN

    CompanyDatePrice TargetRatingAnalyst
    Arcellx Inc.
    $ACLX
    2/12/2026$82.00Buy → Neutral
    Rothschild & Co Redburn
    Sally Beauty Holdings Inc. (Name to be changed from Sally Hold
    $SBH
    1/21/2026$19.00Mkt Perform → Outperform
    Raymond James
    Sally Beauty Holdings Inc. (Name to be changed from Sally Hold
    $SBH
    1/14/2026$16.00Buy → Hold
    Jefferies
    Arcellx Inc.
    $ACLX
    1/7/2026$100.00Buy
    UBS
    Arcellx Inc.
    $ACLX
    12/22/2025$100.00Overweight
    Wells Fargo
    Koninklijke Philips N.V. NY Registry Shares
    $PHG
    12/17/2025Sector Perform
    RBC Capital Mkts
    PROG Holdings Inc.
    $PRG
    12/16/2025$50.00Buy
    B. Riley Securities
    PROG Holdings Inc.
    $PRG
    11/21/2025$31.00Sell → Neutral
    BTIG Research
    More analyst ratings

    $ACIU
    $ACLX
    $ACOR
    $ADN
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Large owner Chernett Jorey bought $257,211 worth of shares (105,848 units at $2.43), increasing direct ownership by 2% to 6,592,059 units (SEC Form 4)

    4 - Airsculpt Technologies, Inc. (0001870940) (Issuer)

    3/16/26 6:43:51 PM ET
    $AIRS
    Medical/Nursing Services
    Health Care

    Large owner Chernett Jorey bought $91,200 worth of shares (45,600 units at $2.00), increasing direct ownership by 0.72% to 6,398,211 units (SEC Form 4)

    4 - Airsculpt Technologies, Inc. (0001870940) (Issuer)

    3/9/26 8:40:24 AM ET
    $AIRS
    Medical/Nursing Services
    Health Care

    Large owner Chernett Jorey bought $192,900 worth of shares (110,000 units at $1.75), increasing direct ownership by 2% to 6,352,611 units (SEC Form 4)

    4 - Airsculpt Technologies, Inc. (0001870940) (Issuer)

    3/4/26 6:58:41 PM ET
    $AIRS
    Medical/Nursing Services
    Health Care

    $ACIU
    $ACLX
    $ACOR
    $ADN
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 3 filed by new insider Chen Jing Veronica

    3 - Bon Natural Life Ltd (0001816815) (Issuer)

    4/23/26 6:15:32 AM ET
    $BON
    Medicinal Chemicals and Botanical Products
    Health Care

    SEC Form 4 filed by Cox Erin Nealy

    4 - Sally Beauty Holdings, Inc. (0001368458) (Issuer)

    4/22/26 5:00:10 PM ET
    $SBH
    Other Specialty Stores
    Consumer Discretionary

    SEC Form 4 filed by Van Well Daan

    4 - SOPHiA GENETICS SA (0001840706) (Issuer)

    4/21/26 4:04:38 PM ET
    $SOPH
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $ACIU
    $ACLX
    $ACOR
    $ADN
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Philips launches new Bridge Plus Occlusion Balloon to help manage rare but life-threatening SVC tears during lead extraction

    April 23, 2026   Bridge Plus was designed for rare, life-threatening emergencies to help control bleeding during superior vena cava (SVC) tears, which occur in <0.5% of lead extraction procedures [1] but require immediate intervention Bridge Plus allows for rapid response when every second counts by deploying in under two minutes [2] and stopping up to 90% blood loss [3], helping stabilize patients with 30 minutes of hemostasis [4]Bridge Plus was built upon proven Bridge Occlusion Balloon technology, used in more than 50,000 U.S. procedures [5,*], with evidence showing improved survival when staged in advance [6,**] Amsterdam, the Netherlands – Royal Philips (NYSE:PHG, AEX: PHIA)), a globa

    4/23/26 9:00:00 AM ET
    $PHG
    Medical Electronics
    Health Care

    Sidus Space Advances its Fortis Next-Generation Command and Data Handling (C&DH) System

    Microchip collaboration enables accelerated, modular, and mission‑scalable OpenVPX architectures for space and defense applications CAPE CANAVERAL, Fla., April 23, 2026 /PRNewswire/ -- Sidus Space, Inc. (NASDAQ:SIDU) ("Sidus" or the "Company"), an innovative space and defense technology company, today announced continued advancements to its Fortis Command and Data Handling (C&DH) platform, a modular 3U OpenVPX system designed to support rapid development, configuration flexibility, and long-term scalability across next-generation space and defense missions. Supported by a strate

    4/23/26 8:31:00 AM ET
    $SIDU
    Telecommunications Equipment
    Telecommunications

    New PROG Holdings Research Offers Insight into Near- and Below-Prime Consumer Behavior

    Survey data explores the state of financial wellness among working Americans and frames flexible payments as essential financial tools In recognition of Financial Literacy Month, PROG Holdings, Inc. ((PRG), a fintech holding company providing transparent and competitive payment solutions and inclusive consumer financial products, today released new research exploring the financial realities facing America's near- and below-prime consumers. The research provides insights into how working Americans with limited financial flexibility are managing rising costs, economic uncertainty, and everyday financial decisions. The research shows that most near- and below-prime consumers are employed a

    4/22/26 6:54:00 PM ET
    $PRG
    Diversified Commercial Services
    Consumer Discretionary

    $ACIU
    $ACLX
    $ACOR
    $ADN
    SEC Filings

    View All

    Amendment: SEC Form 10-K/A filed by Arcellx Inc.

    10-K/A - Arcellx, Inc. (0001786205) (Filer)

    4/24/26 4:38:08 PM ET
    $ACLX
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    SEC Form 6-K filed by Cango Inc.

    6-K - Cango Inc. (0001725123) (Filer)

    4/22/26 4:04:20 PM ET
    $CANG
    Computer Software: Prepackaged Software
    Technology

    Heartcore Enterprises Inc. filed SEC Form 8-K: Regulation FD Disclosure, Other Events, Financial Statements and Exhibits

    8-K - HeartCore Enterprises, Inc. (0001892322) (Filer)

    4/22/26 8:30:28 AM ET
    $HTCR
    EDP Services
    Technology

    $ACIU
    $ACLX
    $ACOR
    $ADN
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Arcellx downgraded by Rothschild & Co Redburn with a new price target

    Rothschild & Co Redburn downgraded Arcellx from Buy to Neutral and set a new price target of $82.00

    2/12/26 7:20:24 AM ET
    $ACLX
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Sally Beauty upgraded by Raymond James with a new price target

    Raymond James upgraded Sally Beauty from Mkt Perform to Outperform and set a new price target of $19.00

    1/21/26 8:30:43 AM ET
    $SBH
    Other Specialty Stores
    Consumer Discretionary

    Sally Beauty downgraded by Jefferies with a new price target

    Jefferies downgraded Sally Beauty from Buy to Hold and set a new price target of $16.00

    1/14/26 8:27:37 AM ET
    $SBH
    Other Specialty Stores
    Consumer Discretionary

    $ACIU
    $ACLX
    $ACOR
    $ADN
    Leadership Updates

    Live Leadership Updates

    View All

    Flow Sciences Appoints Michael Gesser as Chief Financial Officer

    Life Sciences Finance Veteran and Flow Sciences Board Member Steps Into CFO Role to Support Company's Next Phase of GrowthRALEIGH, N.C, April 8, 2026 /PRNewswire/ -- Flow Sciences, Inc., a global leader in advanced containment solutions for laboratory and pharmaceutical environments, today announced the appointment of Michael Gesser as its chief financial officer. Gesser, who has served as a member of the Flow Sciences board of directors since 2021, will continue serving on the board while assuming executive responsibility for all finance, accounting, tax, treasury, FP&A and investor relations functions.

    4/8/26 8:00:00 AM ET
    $ACOR
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Sally Beauty Holdings Appoints Adrianne Lee as Chief Financial Officer

    Marlo Cormier to Step Down to Pursue Other Opportunities Reaffirms Second Quarter and Fiscal Year 2026 Guidance Sally Beauty Holdings, Inc. (NYSE:SBH) ("the Company") today announced that Adrianne Lee has been appointed Senior Vice President and Chief Financial Officer, effective April 28, 2026. Ms. Lee succeeds Marlo Cormier, who will be leaving the company, effective April 11, 2026, to pursue other opportunities. Ms. Lee brings significant relevant experience to the role, most recently serving as President and CFO at Bed Bath & Beyond. Ms. Lee joined Bed Bath & Beyond as CFO in 2020 and became Chief Administrative Officer in 2024 and President in 2025. Prior to that, she held senior

    4/2/26 6:45:00 AM ET
    $SBH
    Other Specialty Stores
    Consumer Discretionary

    Philips proposes new appointment and re-appointments to its Supervisory Board and CEO re-appointment

    March 23, 2026 John DeFord proposed as new member of the Supervisory Board.Paul Stoffels, Herna Verhagen and Sanjay Poonen proposed for re-appointment as members of the Supervisory Board.Marc Harrison will step down from Philips' Supervisory Board after his second term.Roy Jakobs proposed for re-appointment as President/CEO and Chairman and member of the Board of Management, as previously announced. Amsterdam, the Netherlands – Royal Philips (NYSE:PHG, AEX: PHIA)), a global leader in health technology, today announced a proposed Supervisory Board appointment and re-appointments, in addition to the previously announced proposal to re-appointment its President/CEO. The Supervisory Board wil

    3/23/26 4:30:00 AM ET
    $PHG
    Medical Electronics
    Health Care

    $ACIU
    $ACLX
    $ACOR
    $ADN
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by Flora Growth Corp.

    SC 13D/A - Flora Growth Corp. (0001790169) (Subject)

    12/17/24 8:02:53 PM ET
    $FLGC
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SC 13D/A filed by Flora Growth Corp.

    SC 13D/A - Flora Growth Corp. (0001790169) (Subject)

    12/17/24 8:01:40 PM ET
    $FLGC
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SC 13G/A filed by AC Immune SA

    SC 13G/A - AC Immune SA (0001651625) (Subject)

    12/13/24 5:15:16 PM ET
    $ACIU
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ACIU
    $ACLX
    $ACOR
    $ADN
    Financials

    Live finance-specific insights

    View All

    SOPHiA GENETICS to Announce Financial Results for First Quarter 2026 on May 5, 2026

    BOSTON and ROLLE, Switzerland, April 21, 2026 /PRNewswire/ -- SOPHiA GENETICS (NASDAQ:SOPH), a global leader in AI-driven precision medicine, today announced it will release its financial results for the first quarter 2026 before U.S. markets open on Tuesday, May 5, 2026. On that day, SOPHiA GENETICS will host a conference call to discuss its financial results as well as business outlook beginning at 8:00 a.m. (08:00) EDT / 2:00 p.m. (14:00) CET. The call will be webcast live on the SOPHiA GENETICS Investor Relations Website. Additionally, a replay will be available on the websi

    4/21/26 8:00:00 AM ET
    $SOPH
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    PROG Holdings, Inc. to Release First Quarter 2026 Financial Results on April 29, 2026

    PROG Holdings, Inc. (NYSE:PRG), the fintech holding company for Progressive Leasing, Four Technologies, MoneyApp and Purchasing Power, is scheduled to release financial results for the first quarter of 2026 on Wednesday, April 29, 2026 prior to the market open. The Company has also scheduled a live webcast for April 29, 2026 at 8:30 A.M. ET to discuss its financial results for the first quarter of 2026. The webcast can be accessed via the below link, or through the Events & Presentations section of the PROG Holdings investor relations website, https://investor.progholdings.com. Webcast Link: https://edge.media-server.com/mmc/p/jzvx4mf6 About PROG Holdings, Inc. PROG Holdings, Inc. (

    4/7/26 4:15:00 PM ET
    $PRG
    Diversified Commercial Services
    Consumer Discretionary

    CORRECTION -- AirSculpt Technologies Reports Fourth Quarter and Full Year Fiscal 2025 Results

    MIAMI BEACH, Fla., April 06, 2026 (GLOBE NEWSWIRE) -- In a release issued under the same headline on April 2nd, 2026, by AirSculpt Technologies, Inc. (NASDAQ:AIRS), please note that the Company determined that a one-time non-cash adjustment related to the closure of its London facility was inaccurate in the calculation of Adjusted EBITDA, Adjusted EBITDA Margin, and Adjusted Net (Loss)/Income. The updated release reflects the updated figures. AirSculpt Technologies, Inc. (NASDAQ:AIRS)("AirSculpt" or the "Company"), a national provider of premium body contouring procedures, today announced results for the fourth quarter and twelve months ended December 31, 2025. Yogi Jashnani, Chief Execu

    4/6/26 6:30:00 AM ET
    $AIRS
    Medical/Nursing Services
    Health Care